Back to Search Start Over

Clinical and Cytogenomic Characterization of De Novo 11p14.3-p15.5 Duplication Associated with 18q23 Deletion in an Egyptian Female Infant

Authors :
Hanan H. Afifi
Ghada El-Kamah
Shymaa H Hussein
Alaa K. Kamel
Sayda Hammad
Amal M. Mohamed
Mohammed M. Sayed-Ahmed
Sally G. Abd Allah
Source :
J Pediatr Genet
Publication Year :
2020
Publisher :
Georg Thieme Verlag KG, 2020.

Abstract

Paternal microduplication of 11p14.3-p15.5 causes the clinical manifestations of Beckwith–Wiedemann syndrome (BWS), while microdeletion of 18q23-ter is clinically characterized by short stature, congenital malformations, and developmental delay. We describe a 15-month-old girl presenting with protruding tongue, dysmorphic facial features, moderate developmental delay, umbilical hernia, hypotonia, mild-to-moderate pulmonary hypertension, small patent ductus arteriosus, and mild ventricular septal hypertrophy. Brain magnetic resonance imaging showed mild atrophic changes. Chromosomal analysis revealed 46, XX, add(18)(q23). Fluorescence in situ hybridization using subtelomere 18q and whole chromosome painting 18 showed subtelomere deletion in 18q, and the add segment was not derived from chromosome 18. Microarray-based comparative genomic hybridization detected a 22 Mb duplication of chromosome 11p15.5p14.3 and a 3.7 Mb deletion of chromosome 18q23. The phenotype of the chromosomal rearrangements is probably resulted from a combination of dosage-sensitive genes. Our patient had clinical manifestations of both 18q deletion and BWS.

Details

ISSN :
2146460X and 21464596
Volume :
10
Database :
OpenAIRE
Journal :
Journal of Pediatric Genetics
Accession number :
edsair.doi.dedup.....43fd75b1830219d3d407c2ad7671e087
Full Text :
https://doi.org/10.1055/s-0040-1708554